Authors
Chie Nitta, Moemi Shibasaki, Yuko Urayama, Yosuke Yumoto, Hitoshi Maesato, Takeo Muto, Yuhei Amano, Yoshiki Koga, Tomomi Toyama, Ryuhei So, Kohei Kitagawa, Masayuki Ohishi, Masayuki Minami, Mitsuru Kimura, Sachio Matsushita
Published in
PCN reports : psychiatry and clinical neurosciences. Volume 5. Issue 3. Pages e70379. Epub Aug 07, 2026.
Abstract
While "controlled drinking" as a treatment goal for alcohol use disorder (AUD) has recently become accepted in Japan, knowledge regarding the clinical characteristics and drinking patterns of patients with AUD remains limited. This study aimed to describe the gender-stratified baseline clinical characteristics and drinking patterns of treatment-seeking patients with AUD using baseline data from the Alcohol Longitudinal Prognosis Study in Japan (ALPS-J), a multicenter cohort study conducted at 15 facilities nationwide.
The diagnosis and severity of AUD were assessed using the Structured Clinical Interview for DSM-5 Research Version (SCID-5-RV). Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9). Sleep quality was assessed using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J). Drinking patterns were assessed using an original questionnaire.
A total of 354 participants were analyzed; 83.1% were male, the mean age was 51.9 ± 11.2 years, and 85.0% were inpatients. Overall, 80.8% met the diagnostic criteria for severe AUD. Treatment was started approximately 5 years after the onset of drinking problems. Comorbid depressive symptoms were observed in 44.7% of participants, and 74.3% reported poor sleep quality. The mean daily pure alcohol consumption was 110.4 g. The most commonly consumed type of alcoholic beverage was chu-hai with 9% alcohol by volume, a high-alcohol beverage commonly sold in Japan and often referred to as "strong-style" chu-hai.
Patients with AUD treated in specialized addiction treatment facilities often present with severe and complex clinical profiles, highlighting the need for earlier engagement in care and integrated treatment approaches.
PMID:
42569123
Bibliographic data and abstract were imported from PubMed on 08 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0